The Russian vaccine against the Ebola virus is ready

The Russian vaccine against Ebola virus, developed by the Center for Virology and Biotechnology Vektor (Novosibirsk province), is ready for use, the manufacturer said. “The Ebola vaccine has not only successfully passed clinical trials, it has also been registered with the Russian Ministry of Health,” center director Nikolai Krasnikov told Sputnik.

The first batch of the vaccine is already manufactured, he said. “If it is necessary to produce it on a larger scale, a special production will be organized, but at the moment it is enough with what Vektor manufactures,” he said.

The Ebola virus is an acute viral infection that affects humans and certain animal species. The epidemic, which broke out in 2015, affected mainly three countries: Guinea, Sierra Leone and Liberia.

The head of the Russian Federal Service for Consumer Protection, Anna Popova, explained previously that the vaccine is designed primarily for those who are constantly working on the focus of the Ebola virus. The drug, she said, may eliminate the risks of infection among doctors. In addition, the vaccine can be used repeatedly, it is distinguished from all analogues by a greater efficacy and versatility of use.

Ebola cases increase in the Congo

A recent Unicef statement reports an increase in the Ebola outbreak in the Democratic Republic of the Congo, which has killed 460 people and affected another 740 since the beginning of the epidemic in early August.

It is the tenth outbreak of Ebola in the Democratic Republic of the Congo and the worst for the country. Since the epidemic was declared six months ago, on August 1, 2018, there have been more than 740 people – of which 30% are children – infected by the disease, more than 460 dead and 258 survivors.

In addition, it is also the Ebola outbreak most widespread in history after that of West Africa between 2014 and 2016, which was the most terrifying epidemic in recent years and left a dramatic number of dead (11,300) and infected (28,000).

Unicef is expanding its response

“Although we were able to control the disease to a large extent in Mangina, Beni and Komanda, the Ebola virus continues to spread in the Butembo area, mainly due to insecurity and displacement of the population,” said Gianfranco Rotigliano, Unicef Representative in the Democratic Republic of the Congo.

“We are expanding our response and using additional staff resources in the health areas of Butembo and Katwa, where 65% of new cases of Ebola have been found in the last three weeks.”

In addition, since the epidemic began, Unicef and its partners have employed more than 650 staff members to help affected individuals and families and to disseminate more information about best practices in hygiene and behavior to prevent the spread of Ebola.

“Our teams in Mangina, Beni, Oicha, Komanda, Butembo and Lubero work tirelessly with a multi-purpose approach to end the Ebola virus epidemic as quickly as possible and to help affected children and families,” concludes Rotigliano.


With info from Sputnik & Vatican News

Noticias | News

You may also like...

2 Responses

  1. febrero 7, 2019

    […] You can read > The Russian vaccine against the Ebola virus is ready […]

  2. febrero 12, 2019

    […] You can also read > The Russian vaccine against the Ebola virus is ready […]

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.